Citigroup’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$89 Sell
42
-6,565
-99% -$13.9K ﹤0.01% 4768
2025
Q1
$8.06K Sell
6,607
-9,467
-59% -$11.6K ﹤0.01% 4450
2024
Q4
$20.7K Buy
16,074
+1,330
+9% +$1.72K ﹤0.01% 4410
2024
Q3
$40.5K Buy
14,744
+10,259
+229% +$28.2K ﹤0.01% 4283
2024
Q2
$10.1K Buy
+4,485
New +$10.1K ﹤0.01% 4394
2024
Q1
Sell
-10,650
Closed -$17.7K 4849
2023
Q4
$17.7K Buy
+10,650
New +$17.7K ﹤0.01% 4275
2021
Q3
Sell
-557
Closed -$2K 5184
2021
Q2
$2K Sell
557
-1,905
-77% -$6.84K ﹤0.01% 5288
2021
Q1
$5K Sell
2,462
-4,992
-67% -$10.1K ﹤0.01% 5218
2020
Q4
$17K Buy
7,454
+5,667
+317% +$12.9K ﹤0.01% 4703
2020
Q3
$5K Sell
1,787
-3,476
-66% -$9.73K ﹤0.01% 4654
2020
Q2
$16K Sell
5,263
-6,932
-57% -$21.1K ﹤0.01% 4389
2020
Q1
$24K Buy
12,195
+4,166
+52% +$8.2K ﹤0.01% 4269
2019
Q4
$23K Buy
8,029
+5,842
+267% +$16.7K ﹤0.01% 4438
2019
Q3
$8K Sell
2,187
-6,847
-76% -$25K ﹤0.01% 4646
2019
Q2
$37K Sell
9,034
-49,339
-85% -$202K ﹤0.01% 4284
2019
Q1
$298K Buy
+58,373
New +$298K ﹤0.01% 2857
2016
Q2
Sell
-191
Closed 5046
2016
Q1
$0 Sell
191
-1,134
-86% ﹤0.01% 5411
2015
Q4
$2K Buy
+1,325
New +$2K ﹤0.01% 5141
2015
Q2
Sell
-1,098
Closed -$4K 5598
2015
Q1
$4K Sell
1,098
-2,134
-66% -$7.77K ﹤0.01% 5066
2014
Q4
$11K Buy
3,232
+1,284
+66% +$4.37K ﹤0.01% 4818
2014
Q3
$10K Buy
1,948
+1,796
+1,182% +$9.22K ﹤0.01% 4624
2014
Q2
$2K Sell
152
-279
-65% -$3.67K ﹤0.01% 5100
2014
Q1
$7K Buy
431
+195
+83% +$3.17K ﹤0.01% 4936
2013
Q4
$2K Buy
+236
New +$2K ﹤0.01% 5172